AVXL · NASDAQ

Anavex Life Sciences Corp.

Q: How do I get AVXL news from the API?

Call GET /v1/news?tickers=AVXL. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.

$1.29 0.00 (+0.37%)

Company overview

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company focused on developing drug candidates for the treatment of central nervous system diseases. Its lead drug candidate, ANAVEX 2-73, is in Phase III clinical trials for Alzheimer's disease and for pediatric patients with Rett syndrome; Phase II trials for Parkinson's disease; and preclinical trials for epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company is also developing ANAVEX 3-71, which is in Phase I clinical trials for frontotemporal dementia and other dementia indications, with preclinical trials for neurodegenerative diseases including Alzheimer's and Parkinson's.

Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
Market cap: $120M
Employees: 42
Headquarters: New York City, NY
Website: anavex.com
CEO: Christopher U. Missling
Listed: August 2, 2006
P/E: -2.78
Dividend yield: 0.00%

Company financials

Revenue: $0.00
Gross profit: $0.00
Operating income: -$44.6M
EBITDA: -$40M
Net income: -$39.9M
EPS: -$0.46
Total assets: $133M
Total debt: $0.00
Earnings yield: -35.95%

Price chart

AVXL 1D NASDAQ O1.34H1.34L1.30C1.32-0.04 (-2.94%)Vol239.46K

News

Ticker	Type	Headline	Source	Published
AVXL	Legal	ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AVXL	Newsfile Corp	Oct 23, 9:19:00 PM ET
AVXL	Legal	Pomerantz LLP Issues Reminder to Investors in Anavex Life Sciences Corp. of Class Action – AVXL	ACCESS Newswire	Oct 23, 6:00:00 PM ET
AVXL	Legal	What Does Anavex Life Sciences Corp.'s 6.35% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action Lead Plaintiff Deadline The Law Offices of Howard G.	PR Newswire	Oct 23, 1:30:00 PM ET
AVXL	Legal	AVXL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Anavex (AVXL) Investors of Securities Class Action Lawsuit Deadline on November 30, 2026	Newsfile Corp	Oct 23, 7:24:00 AM ET
AVXL	Legal	Pomerantz LLP Issues Reminder to Shareholders in Anavex Life Sciences Corp. of Class Action Filing – AVXL	ACCESS Newswire	Oct 23, 7:00:00 AM ET
AVXL	Legal	Kaplan Fox Alerts Investors of Anavex Life Sciences Corp. (AVXL) with Significant Losses to a Securities Class Action Deadline on November 30, 2026	Newsfile Corp	Oct 23, 3:15:00 AM ET
AVXL	Legal	ROSEN, A NATIONAL LAW FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AVXL	Newsfile Corp	Oct 22, 7:01:00 PM ET
AVXL	Legal	What Should Anavex Life Sciences Corp. Investors Know After 6.35% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline	GuruFocus	Oct 22, 2:00:00 PM ET
AVXL	Legal	What Should Anavex Life Sciences Corp. Investors Know After 6.35% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline The Law Offices of Frank R.	PR Newswire	Oct 22, 1:00:00 PM ET
AVXL	Legal	Robbins LLP Urges AVXL Stockholders Who Lost Money Investing in Anavex Life Sciences Corp. to Contact the Firm for Information About Leading the Class Action	Business Wire	Oct 22, 12:28:00 PM ET
AVXL	Legal	Kaplan Fox Reminds Investors of Anavex Life Sciences Corp. (NASDAQ: AVXL) to a Securities Class Action Deadline - Contact the Firm Before November 30, 2026	ACCESS Newswire	Oct 22, 4:00:00 AM ET
AVXL	Legal	Pomerantz LLP Issues Reminder to Anavex Life Sciences Corp. Shareholders – AVXL	ACCESS Newswire	Oct 21, 8:00:00 PM ET
AVXL	Legal	ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL	GlobeNewswire	Oct 21, 6:56:00 PM ET
AVXL	Legal	DEADLINE ALERT for Fluence Energy, Inc. (FLNC), Qfin Holdings, Inc. (QFIN), Endava plc (DAVA), and Anavex Life Sciences Corp. (AVXL): The Law Offices of Frank R.	GlobeNewswire	Oct 21, 12:08:00 PM ET
AVXL	Press release	Brain Cancer Research: The Race for Better CNS Cancer Treatments Could Open a Multibillion-Dollar Market	GlobeNewswire	Oct 21, 10:40:00 AM ET
AVXL	Legal	Pomerantz LLP Issues Reminder to Shareholders in Anavex Life Sciences Corp. of Class Action – AVXL	ACCESS Newswire	Oct 21, 7:00:00 AM ET
AVXL	Legal	INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines - AVXL	GlobeNewswire	Oct 20, 4:01:00 PM ET
AVXL	Press release	Anavex Provides Corporate Update, Announces Completion of Clinical Conduct of ADME and DDI Clinical Studies	GlobeNewswire	Oct 20, 4:00:00 PM ET
AVXL	Legal	AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp.	PR Newswire	Oct 20, 3:45:00 PM ET
AVXL	Legal	Kaplan Fox Encourages Investors of Anavex Life Sciences Corp. (NASDAQ:AVXL) to Contact the Firm to Learn About Their Legal Rights	ACCESS Newswire	Oct 20, 7:50:00 AM ET

FAQ

Questions about Anavex Life Sciences Corp.

What does Anavex Life Sciences Corp. do?

What is AVXL's market cap?

Anavex Life Sciences Corp. (AVXL) is a listed stock with a live quote. The latest market cap on this page is $120M.

Where is Anavex Life Sciences Corp. headquartered?

Anavex Life Sciences Corp. is headquartered in New York City, NY.

How do I get AVXL news from the API?

Call GET /v1/news?tickers=AVXL. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.

How far back does AVXL news go?

Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for AVXL, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.

Is the AVXL price on this page from the API?

The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs